Randall L. Kuffel, BS; Ruth T. Morin, PhD; Kenneth E. Covinsky, MD, MPH; et al.
free access
JAMA Psychiatry. 2023;80(4):287-295. doi:10.1001/jamapsychiatry.2022.5144
This cohort study examines the association of frailty with risk of suicide attempt and suicide death in a nationwide sample of US veterans aged 65 years or older.
Kristin Köhler-Forsberg, PhD; Vibeke H. Dam, PhD; Brice Ozenne, PhD; et al.
free access
JAMA Psychiatry. 2023;80(4):296-304. doi:10.1001/jamapsychiatry.2022.4539
This case-control study compares levels of serotonin type 4 receptor as well as verbal memory, working memory, reaction time, emotion recognition bias, and negative social emotions in unmedicated patients with major depressive disorder vs individuals without this diagnosis.
Teng Yang, BD; Jiawei Wang, BD; Jing Huang, PhD; et al.
free access
JAMA Psychiatry. 2023;80(4):305-313. doi:10.1001/jamapsychiatry.2022.4812
This cohort study investigates the association of long-term exposure to multiple air pollutants and incident depression and anxiety.
Kenneth S. Kendler, MD; Linda Abrahamsson, PhD; Henrik Ohlsson, PhD; et al.
free access
JAMA Psychiatry. 2023;80(4):314-322. doi:10.1001/jamapsychiatry.2022.4777
This population register–based study examines data for offspring born in Sweden from 1960 to 1995 to evaluate the sources of parent-offspring transmission of OCD and its familial cross-generational association with more typical anxiety disorders.
Josef Isung, MD, PhD; Kayoko Isomura, MD, PhD; Kyle Williams, MD, PhD; et al.
free access
JAMA Psychiatry. 2023;80(4):323-330. doi:10.1001/jamapsychiatry.2022.4786
This cohort study assesses whether an association exists between psychiatric disorders and suicidal behavior in parents and development of the same outcomes in their offspring in a Swedish cohort.
Lyna Z. Schieber, MD, DPhil; Christopher Dunphy, PhD; Richard A. Schieber, MD, MPH; et al.
free access
JAMA Psychiatry. 2023;80(4):331-341. doi:10.1001/jamapsychiatry.2022.5047
This cross-sectional study examines hospital discharge data for adults with a COVID-19 diagnosis to assess the association of comorbid psychiatric and substance use disorders with hospitalization among emergency department patients with COVID-19.
Thomas T. van Sloten, MD; Eugénie Valentin, MSc; Rachel E. Climie, PhD; et al.
free access
JAMA Psychiatry. 2023;80(4):342-349. doi:10.1001/jamapsychiatry.2022.5056
This cohort study evaluates whether better baseline cardiovascular health and improvement of cardiovascular health over time are associated with a lower risk of both incident depressive symptoms and unfavorable trajectories of depressive symptoms.
Frederikke Hørdam Gronemann, PhD, Msc; Rikke Kart Jacobsen, Msc; Marie Kim Wium-Andersen, DMSc; et al.
free access
JAMA Psychiatry. 2023;80(4):350-359. doi:10.1001/jamapsychiatry.2022.4965
This cohort study examines the association between family major depression history and risk of major depression including association with age, sex, type of kinship, and age of the affected family member.
Weiming Gong, MM; Ping Guo, MM; Yuanming Li, BM; et al.
open access
JAMA Psychiatry. 2023;80(4):360-370. doi:10.1001/jamapsychiatry.2022.4974
This genome-wide pleiotropic association study sequentially investigates the pleiotropic associations from genetic and biological pathways to disentangle the underlying shared genetic etiology between 4 gastrointestinal tract diseases and 6 psychiatric disorders.
Helene Gjervig Hansen, MD; Marie Starzer, MD; Sandra Feodor Nilsson, PhD; et al.
free access
has audio
JAMA Psychiatry. 2023;80(4):371-379. doi:10.1001/jamapsychiatry.2022.5164
This 20-year follow-up of a randomized clinical trial reports the long-term associations of early intervention services compared with treatment as usual for individuals with first-episode schizophrenia spectrum disorder.
-
Podcast:
Specialized Early Intervention Services vs Treatment as Usual For First-Episode Schizophrenia Spectrum Disorder
Deborah S. Hasin, PhD; Melanie M. Wall, PhD; C. Jean Choi, MS; et al.
open access
JAMA Psychiatry. 2023;80(4):380-388. doi:10.1001/jamapsychiatry.2023.0019
This observational study assesses the role of medical cannabis law and recreational cannabis law enactment in diagnosed cannabis use disorder prevalence among Veterans Health Administration patients by using yearly electronic medical record data from 2005 to 2019.
Marta Peciña, MD, PhD; Jiazhou Chen, BS; Jordan F. Karp, MD; et al.
free access
JAMA Psychiatry. 2023;80(4):389-398. doi:10.1001/jamapsychiatry.2023.0010
This cross-sectional study investigates the neurobehavioral mechanisms associated with antidepressant placebo effects over time using a reinforcement learning framework.